Vaping and waterpipes ‘multiply risks of developing lung diseases’

Both smoking and vaping can stiffen the arteries and increase the risk of developing adverse lung conditions, scientists have said. Their findings are based on a clinical review of the available evidence gathered from multiple studies. An analysis by an international team of researchers found that tobacco cigarettes, in general, were more harmful than electronic… Read More: Vaping and waterpipes ‘multiply risks of developing lung diseases’ »

FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by… Read More: FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients… »